Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [Acute paroxysmal attack (decompensation) in the initial stage of primary glaucoma].

Literature DB >> 5381938

[Acute paroxysmal attack (decompensation) in the initial stage of primary glaucoma].

B L Poliak, E N Indeĭkin.

Abstract

Entities: Disease

Mesh：

Year: 1969 PMID： 5381938

Source DB: PubMed Journal: Vestn Oftalmol ISSN： 0042-465X

Keyword Cloud
Cited

× No keyword cloud information.

7 in total

Review 1. Clinical development of immunotherapies for HER2⁺ breast cancer: a review of HER2-directed monoclonal antibodies and beyond.

Authors: Ricardo L B Costa; Brian J Czerniecki
Journal: NPJ Breast Cancer Date: 2020-03-12

2. Endometrial Tumour Microenvironment.

Authors: Carlos Casas-Arozamena; Miguel Abal
Journal: Adv Exp Med Biol Date: 2020 Impact factor: 2.622

3. A comparative view on the expression patterns of PD-L1 and PD-1 in soft tissue sarcomas.

Authors: Thomas G P Grünewald; Thomas Knösel; Martin F Orth; Veit Leonhard Buecklein; Eric Kampmann; Marion Subklewe; Elfriede Noessner; Florencia Cidre-Aranaz; Laura Romero-Pérez; Fabienne Sophie Wehweck; Lars Lindner; Rolf Issels; Thomas Kirchner; Annelore Altendorf-Hofmann
Journal: Cancer Immunol Immunother Date: 2020-03-28 Impact factor: 6.968

4. Lauren classification identifies distinct prognostic value and functional status of intratumoral CD8⁺ T cells in gastric cancer.

Authors: Ruochen Li; Heng Zhang; Yifan Cao; Xin Liu; Yifan Chen; Yangyang Qi; Jieti Wang; Kuan Yu; Chao Lin; Hao Liu; Hongyong He; He Li; Lingli Chen; Zhenbin Shen; Jing Qin; Weijuan Zhang; Yihong Sun; Jiejie Xu
Journal: Cancer Immunol Immunother Date: 2020-03-21 Impact factor: 6.968

[Acute paroxysmal attack (decompensation) in the initial stage of primary glaucoma].

Review 1. Clinical development of immunotherapies for HER2⁺ breast cancer: a review of HER2-directed monoclonal antibodies and beyond.

2. Endometrial Tumour Microenvironment.

3. A comparative view on the expression patterns of PD-L1 and PD-1 in soft tissue sarcomas.

4. Lauren classification identifies distinct prognostic value and functional status of intratumoral CD8⁺ T cells in gastric cancer.

5. ALDH2 polymorphism rs671 is a predictor of PD-1/PD-L1 inhibitor efficacy against thoracic malignancies.

6. Understanding and Targeting Human Cancer Regulatory T Cells to Improve Therapy.

7. PMS2 germline mutation c.943C>T (p.Arg315*)-induced Lynch syndrome-associated ovarian cancer.

[Acute paroxysmal attack (decompensation) in the initial stage of primary glaucoma].

Review 1. Clinical development of immunotherapies for HER2+ breast cancer: a review of HER2-directed monoclonal antibodies and beyond.

2. Endometrial Tumour Microenvironment.

3. A comparative view on the expression patterns of PD-L1 and PD-1 in soft tissue sarcomas.

4. Lauren classification identifies distinct prognostic value and functional status of intratumoral CD8+ T cells in gastric cancer.

5. ALDH2 polymorphism rs671 is a predictor of PD-1/PD-L1 inhibitor efficacy against thoracic malignancies.

6. Understanding and Targeting Human Cancer Regulatory T Cells to Improve Therapy.

7. PMS2 germline mutation c.943C>T (p.Arg315*)-induced Lynch syndrome-associated ovarian cancer.

Review 1. Clinical development of immunotherapies for HER2⁺ breast cancer: a review of HER2-directed monoclonal antibodies and beyond.

4. Lauren classification identifies distinct prognostic value and functional status of intratumoral CD8⁺ T cells in gastric cancer.